9 December 2019PatentsRory O'Neill

SCOTUS urged to reject IPR immunity appeal after Arthrex

The US Supreme Court should not review a University of Minnesota (UMN) state sovereign immunity appeal while the inter partes review (IPR) process remains shrouded in uncertainty, defendant Ericsson has claimed.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

Federal Circuit refuses Arthrex rerun, prerogative now with SCOTUS

24 March 2020 The US Court of Appeals for the Federal Circuit will leave it to the Supreme Court to review its controversial Arthrex decision that Patent Trial and Appeal Board judges were unconstitutionally appointed.

Patents

Fed Circuit rules that PTAB structure is unconstitutional

1 November 2019 The US Court of Appeals for the Federal Circuit yesterday, October 31 ruled that the appointment and oversight of the US Patent and Trademark Office patent review judges was unconstitutional, and expanded the powers of the office’s director to resolve the problem.

UK-India trade deal is ‘missed opportunity’, say industry bodies

SEPs now searchable on WIPO’s global patent database

INTA 2025: San Diego to host largest post-COVID Annual Meeting

'Nothing can stand in the way of our work': Ukraine resumes IP system

Foley adds five-partner team from Perkins Coie and K&L Gates

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Cahill expands practice with three-partner team from King & Spalding

SCOTUS urged to reject IPR immunity appeal after Arthrex

More on this story

Editor's picks

Editor's picks

More articles